cid产品代理
cid产品代理
Cell ID 由 Xander Sim 共同创立，Xander Sim 是用于测试疟疾寄生虫血症、HIV 病毒载量和 COVID-19 的一次性 Quiz 生物芯片 PCR 平台技术的发明者和开发者。测验 SARS-CoV-2 NAT 使用实时 RT-LAMP，完全满足 95%CI 准确度标准。 Cell ID的Quiz Biochip平台技术中使用的加热元件获得了美国专利局的专利授权状态，同时获得了日本、台湾、非洲、印度尼西亚、欧洲、中国和新加坡国家专利局的专利授权。
Cell ID Strives To Provide Fast, Accurate, Affordable And Mass-Deployable Solutions Integrating Engineering With Biological Sciences. We Challenge Traditional Lab Bounded Diagnostics With Point-Of-Care (POC) Solutions. Our Aim Is To Free Limited Lab Resources And Bring Diagnosis Closer To Users.
Established in 2014, Cell ID Pte. Ltd. is a Singapore-incorporated med-tech company that designs, researchs, develops and manufactures diagnostic tests. The company focuses in near-field Point-of-Care (nf-POC) and decentralised molecular diagnostic platform technologies.
Cell ID was co-founded by Xander Sim, who is the inventor and developer of the single-use Quiz biochip PCR platform
echnology for testing Malaria parasitaemia, HIV viral load, and COVID-19. Quiz SARS-CoV-2 NAT uses real-time RT-LAMP, and fully meets the 95%CI accuracy standard. Cell ID obtained patent-granted status for the heating element used in the Quiz Biochip platform technology from the US Patent Office, along with patents granted by national Patent Offices in Japan, Taiwan, Africa, Indonesia, Europe, China, and Singapore.
